Affordable Access

Design, synthesis, and biological evaluation of betulinic acid derivatives as potent anti-HIV-1 agents

Authors
Publisher
University of North Carolina at Chapel Hill. Library
Publication Date
Disciplines
  • Biology
  • Design

Abstract

The overall goals of this research were to design and synthesize novel betulinic acid (BA) derivatives and to evaluate their biological activities, establish structure-activity relationships (SAR), and investigate mechanism(s) of action. Three specific goals were identified in this study: 1) establish the detailed SAR of C-3 modified BA analogs for HIV-1 maturation inhibitors and further improve antiviral activity profiles; 2) investigate the impacts of C-19 isopropenyl moiety to the antiviral activity and develop 28,30-disubstituted BA analogs as novel HIV-1 entry inhibitors; 3) develop 3,28-disubstituted BA analogs as bifunctional HIV-1 inhibitors. More than 50 BA derivatives were synthesized and evaluated in HIV-1 replication inhibition assay in this research. Compound 82 with enlarged C-3' substitution of C-3 side chain showed an extremely potent anti-HIV-1 activity with an EC50 value of 0.0006 [mu]M, which was better than the current clinical trial candidates bevirimat (DSB) in HIV-1IIIB infected MT-2 cell line. In contrast, C-30 substitutions through ether bond do not influence the antiviral potency of the derivatives significantly. Incorporation of water-solubilizing moieties into C-30 position can improve the hydropholicity and solubility of the C-28 modified BA derived HIV-1 entry inhibitors significantly, which led to the discovery of 112 with a significant anti-HIV-1 activity (EC50: 0.09 [mu]M) similar to the previous best hints. The C-28 side chain was further modified to increase the metabolic stability, resulting in the identification of novel 3,28-disubstituted BA analogs 131 and 132, with better stability and extremely potent antiviral activities (EC50 ~0.006 [mu]M) which are slightly better than that of bevirimat. In a different project, we discovered that C-3 modification and C-30 modification can increase the anti-proteasome activity of BA dramatically. 3,30-disubstituted BA analogs may be developed into potent proteasome inhibitors and potential anti-cancer agents, which represents another promising direction for the development of BA derivatives.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Anti-AIDS agents. 78. Design, synthesis, metabolic...

on Journal of Medicinal Chemistry May 28, 2009

Anti-AIDS agents 81. Design, synthesis, and struct...

on Journal of Medicinal Chemistry Apr 22, 2010

Betulinic acid and dihydrobetulinic acid derivativ...

on Journal of Medicinal Chemistry Mar 01, 1996

Design, synthesis and biological evaluation of nov...

on Chemistry Central Journal Jan 01, 2012
More articles like this..